Serial proton magnetic resonance spectroscopy of normal-appearing gray and white matter in MS

Neurology

Volumn 80, Issue 1, 2013, Pages 17-18

  Gass, Achim ^a   Richards, Todd L ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

BRAIN SIZE; CELL DEATH; DISEASE COURSE; EDITORIAL; EXPANDED DISABILITY STATUS SCALE; GLIOSIS; GRAY MATTER; HUMAN; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REMYELINIZATION; WHITE MATTER;

EID: 84873633765     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827b1b4c     Document Type: Editorial

References (10)

1. Miller DH, Thompson AJ, Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 2003;250:1407-1419.
2. Sajja BR, Wolinsky JS, Narayana PA. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2009;19:45-58.
3. Kirov II, Tal A, Babb JS, Herbert J, Gonen O. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS. Neurology 2013;80:39-46.
4. Kapeller P, Brex PA, Chard D, et al. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2002;8:207-210.
5. Fernando KT, McLean MA, Chard DT, et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2004;127:1361-1369.
6. Narayanan S, De Stefano N, Francis GS, et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol 2001;248:979-986.
7. Paling D, Golay X, Wheeler-Kingshott C, Kapoor R, Miller D. Energy failure in multiple sclerosis and its investigation using MR techniques. J Neurol 2011;258:2113-2127.
8. Ziemann U, Wahl M, Hattingen E, Tumani H. Development of biomarkers for multiple sclerosis as a neurodegen-erative disorder. Prog Neurobiol 2011;95:670-685.
9. Filippi M, Rocca M, Barkhof F, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 2012;11:349-360.
10. Posse S, Otazo R, Tsai SY, et al. Single-shot magnetic resonance spectroscopic imaging with partial parallel imaging. Magn Reson Med 2009;61:541-547.